arrow_back Back to App

Funding Cap for HIV/AIDS and Disease Prevention in 2024.

This bill proposes to limit the funds available for a government agency responsible for preventing HIV/AIDS, viral hepatitis, sexually transmitted diseases, and tuberculosis in fiscal year 2024. This means that prevention programs and activities in these areas may receive less money, potentially affecting the availability of health services and information campaigns for citizens.
Key points
The bill sets a maximum amount that the Centers for Disease Control and Prevention (CDC) can allocate for programs related to HIV/AIDS, viral hepatitis, sexually transmitted diseases, and tuberculosis in 2024.
Reduced funding could impact research, prevention, testing, and treatment for these diseases, potentially affecting public and individual health.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_1962
Sponsor: Rep. Biggs, Andy [R-AZ-5]
Process start date: 2023-03-29
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

To provide for a limitation on availability of funds for Department of Health and Human Services, Centers for Disease Control and Prevention HIV/AIDS, Viral Hepatitis, Sexually Transmitted Diseases, and Tuberculosis Prevention for fiscal year 2024.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_1962.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-03-29.

What are the main provisions?

Key points include:

  • The bill sets a maximum amount that the Centers for Disease Control and Prevention (CDC) can allocate for programs related to HIV/AIDS, viral hepatitis, sexually transmitted diseases, and tuberculosis in 2024.
  • Reduced funding could impact research, prevention, testing, and treatment for these diseases, potentially affecting public and individual health.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Biggs, Andy [R-AZ-5].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

CATEGORIES

Health